BOCKORNY GROUP, INC. for CVS HEALTH INC
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Issues related to drug pricing Issues related to health reform proposals Issues related to representation in COVID-19-related packages HR 7213, Equitable Community Access to Pharmacist Services Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFFREY MAXWELL BECKER | — |
| DAVID BOCKORNY | — |
| MARTIN DEPOY | — |
Budget/Appropriations BUD
Issues related to hospital payments Issues related to hospital inclusion and representation in COVID-19 packages; HR 7213 Public Law Number 116-136 CARES Act H.R. 133 Consolidated Appropriations Act, 2021 H.R. 1868 An Act to prevent across-the-board direct spending cuts, and for other purposes HR 5376 Build Back Better Act Budget Reconciliation Legislative Recommendations Relating to Medicaid; Budget Reconciliation Legislative Recommendations Relating to CHIP; Budget Reconciliation Legislative Recommendations Relating to Medicare (Sec. 30801, 30803, 30804, 30805)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEFFREY MAXWELL BECKER | — |
| DAVID BOCKORNY | — |
| MARTIN DEPOY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.